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ABSTRACT 
The study aim was to comprehensively assess physiological function and muscle morphology 
in chronically-trained older individuals against untrained young and older individuals. In a 
cross-sectional design 15 young untrained controls (YC) (20±2.7 y, 78.9±13.3kg), 12 
untrained older controls (OC) (69.8±4.1 y, 77.5±14.2kg) and 14 endurance-trained master 
athletes (MA) (67.1±4.1 y, 68.7±6.5kg) underwent assessments of body composition, aerobic 
capacity, strength, muscle architecture and fibre-type morphology. Skeletal muscle index was 
lower and body fat greater in OC vs. MA. Estimated VO2max (ml·kg-1·min-1) was similar 
between MA and YC, but lower in OC. Isometric leg strength normalized to fat-free mass 
was similar between groups, whereas normalized isometric arm strength was greater in YC 
than MA. Myosin heavy chain (MHC) I fibre area was greater in MA than OC, whilst MHC 
II fibre area was greater in YC than OC.  MHC II fibre myonuclear domain size was greater 
in YC than OC and MA, whereas MA had greater MHC I and MHC II fibre capilliarisation 
than OC and YC. Satellite cell content was similar between groups.  Chronic endurance 
training enhances indices of muscle morphology and improves body composition and aerobic 
capacity in older age, with potentially important implications for healthspan extension.  
 










The shift towards an ageing population presents a significant and overwhelming 
global demand on healthcare resources. The major trepidation is not that individuals are 
living longer (i.e. lifespan), but that they endure a larger portion of their later years with 
multiple age-associated co-morbidities (i.e. healthspan) 1. Thus, strategies to close the gap 
between health- and life-span are of paramount importance.  
Age-related reductions of skeletal muscle mass, strength and function (termed 
‘sarcopenia’) and cardiorespiratory fitness may prematurely force individuals into a state of 
physical dependence and are independent predictors of all-cause mortality 2-4. Skeletal 
muscle mass is indispensable for locomotion, basal metabolism, energy storage and nutrient 
deposition 5. By the 8th decade of life skeletal muscle mass has reduced by ~18% in men and 
27% in women 6 and is accompanied by a greater relative loss of muscle strength 7. 
Sarcopenia is characterised by reductions in muscle fibre cross-sectional area (CSA) 8, 
satellite cell content 9, motor unit remodelling 10, infiltrations of fat and connective tissue 11, 
alterations to the microcirculation 9,12 and reduced oxidative capacity 13. The extent to which 
this physiological deterioration is due to inherent ageing processes, free from artefacts of 
biological ageing that exacerbate the decline (i.e., physical inactivity), is unclear.  
The study of individuals who have chronically undertaken structured exercise training 
and continue to compete, into their later years, referred to as Master Athletes (MA), provides 
a model to investigate the impact of inherent ageing on physiological function, without 
confounding aspects of biological ageing. In a recent meta-analysis, we reported that 
endurance-based MA displayed a 55% greater aerobic capacity compared with age-matched 
untrained individuals, whereas resistance trained MA demonstrated greater strength than age-
matched untrained individuals 14. Furthermore, others have shown that although a decline in 
physiological function remains apparent in MA, high physical activity may ultimately 
 4 
improve the healthspan by shifting the ‘set point’ of age-related physiological deterioration to 
later in life 15,16. Nevertheless, firm conclusions on the influence of ageing and chronic 
exercise on physiological deterioration cannot be drawn, as very few studies have included 
sufficient parameters to comprehensively characterise skeletal muscle morphology at macro- 
and microscopic level in MA 17-19, or have not included a young control group for 
comparison 16,20. The few studies that have investigated aspects of MA physiology and 
muscle morphology report conflicting findings, which may relate to different analytical 
methods or the specific muscle studied. Specifically, some have demonstrated superior leg 
strength and muscle fibre diameter in senior sportsmen compared with untrained older 
individuals  18, whereas others have shown similar muscle size, strength and fibre CSA 
between MA and untrained older individuals 17,19.  
Therefore, to better understand the role of inherent ageing processes in physiological 
function, and the extent to which chronic exercise training might improve the healthspan, the 
aim of the current study was to conduct the most comprehensive comparison, to date, of 
physical function, cardiorespiratory fitness, body composition, muscle strength, architecture 
and fibre-type morphology between MA and healthy untrained younger and age-matched 
older individuals. We hypothesised that untrained older individuals would exhibit an 
impairment in all of the above parameters compared with younger individuals, which would 




Fifteen untrained young men (YC) and 12 older untrained men (OC) were recruited alongside 
14 Master endurance trained men (MA) through local advertisements, the British Masters 
Athletics Federation and the League of Veteran Racing Cyclists. Young (18-35 years) and 
 5 
older untrained controls (60-80 years) were deemed eligible for study participation only if 
they maintained habitual activity and had not previously participated in any form of 
structured exercise training outside of recreational activities. MA (60-80 years) were included 
only if they had maintained continuous endurance training at least twice per week for ≥20 
years preceding the study. Exclusion criteria included regular consumption of analgesic or 
anti-inflammatory drug(s), prescription or non-prescription, that may affect muscle 
metabolism (e.g. Beta-blockers, corticosteroids, non-steroidal anti-inflammatories). 
Participant anthropometric and training characteristics are detailed in Table 1. All 
participants were informed of the purpose and methodology of the study, were deemed 
healthy by completion of a general health questionnaire assessment, and provided their 
written informed consent. Ethical approval was obtained through the West Midlands - 
Solihull Research Ethics Committee (16/WM/0167). The study conformed to the standards 
set by the Declaration of Helsinki (7th version).  
 
Study design 
In a parallel study design, YC, OC and MA were recruited to investigate the effect that 
ageing and continuous endurance exercise exert on indices of muscle mass, function and 
morphology. Following initial study screening and consenting, participants reported to the 
School of Sport, Exercise and Rehabilitation Sciences (SportExR) laboratory on two separate 
occasions with each visit separated by ~7 days. For each visit participants reported to 
SportExR in an overnight fasted-state, having refrained from strenuous physical activity and 
alcohol for at least 48 h previously, and from caffeine consumption on the day of the trial. 
During the initial visit, participants underwent assessments of body composition, aerobic 
capacity, maximal limb strength and a battery of functional tests. Approximately 1 week 
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later, participants underwent ultrasound scanning, a single venous blood sample and a single 
muscle biopsy.  
 
Visit 1 
Body mass, height and composition: Body mass was determined by weighing each 
participant in loose clothing, without shoes, to the nearest 0.1kg using a digital balance scale 
(Esca 813, Hamburg, Germany). Height measurements were made to the nearest 0.1cm using 
a stadiometer (Seca 217, Hamburg, Germany). Participants underwent a dual-energy x-ray 
absorptiometry (DXA) scan (Discovery DXA Systems, Hologic Inc., Bedford, MA) to 
determine whole-body and regional fat- and fat-free mass. Skeletal muscle index was 
calculated as fat-free mass as a percentage of whole-body mass.  
Blood pressure: Blood pressure was measured using a standard fully automatic blood 
pressure monitor (OMRON M2, OMRON Healthcare UK Ltd., UK). Participants were asked 
to remove any clothing that obstructed the blood pressure cuff. Participants were seated with 
their legs uncrossed and back supported, encouraged to relax and refrain from talking during 
the assessment. This test was repeated 3 times and the lowest of 3 readings taken. Following 
blood pressure assessment, participants underwent the Ekblom-Bak submaximal cycle 
ergometry test for the estimation of V̇O2max 21, the details of which are described in the 
supplemental materials.  
Aerobic capacity: Participants underwent the Ekblom-Bak test 21; a submaximal cycle 
ergometry test for the estimation of V̇O2max. Briefly, the test is based on the change in heart 
rate between a standardised low workload and a higher workload predetermined by sex and 
current habitual activity. Participants were instructed to maintain a constant cadence of 60 
rpm throughout the test. First, the participant cycled for 4 min, while investigators ensured 
constant cadence and resistance. Heart rate was recorded every 15 s and averaged during the 
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final minute of the low workload. The Electrocardiogram (ECG) was monitored over 5 min 
prior-to and continuously throughout exercise by a cardiologist. The resistance was then 
increased to the predetermined level for the next 4 min, whilst cadence and resistance 
remained constant. During the second minute at the higher workload, individuals 
communicated their rate perceived exertion (RPE) using a standard scale 22. If RPE was <10 
the resistance was increased by 1kp and the second workload timings started again. If RPE 
was 10-11, the workload was increased by 0.5kp and the second workload timings started 
again. If RPE was 12-16 participants were instructed to maintain this workload. If RPE >17 
the exercise bout was stopped. Heart rate was recorded every 15 s and averaged during the 
final minute of the higher workload. V̇O2max was calculated using the following equation 21:  
?̇?𝑂2𝑚𝑎𝑥 = 4.98196 − 2.88618(
∆𝐻𝑅
∆𝑃𝑂
) + 0.65015(𝑆𝑒𝑥) − 0.01712(𝐴𝑔𝑒) 
Where ΔHR is the difference in the average heart rate between the two workloads, ΔPO is a 
constant reflecting the difference in power output between the two workloads, where sex is 
0=woman and 1=man, and age is participants age in years as an integer. 
Short physical performance battery (SPPB): Participants completed the SPPB of balance, 
gait speed and low limb power 23 The balance test comprised three increasingly difficult 
stances (side-by-side, semi-tandem, full tandem), which participants were required to hold for 
10 sec. For the gait speed test, participants were instructed to walk a 3-metre-long course ‘at 
your usual speed as if walking to the shops’. Finally, participants completed a repeated chair 
stand test, in which they were instructed to rise from a chair, with arms folded, five times as 
quickly as possible. The result from each of the three tests were scored out of 4 marks and 
compared against predetermined criteria for a score of physical function.  
Handgrip and leg strength: Individuals stood, feet side-by-side, with their arms adducted, 
wrists neutrally rotated and the dynamometer (Jamar Hydraulic, Patterson Medical, UK) 
positioned comfortably in the participant’s self-reported dominant hand. Participants were 
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instructed to squeeze the handle as hard as possible and three attempts were recorded, with 
the highest value recorded. Maximal knee extension and elbow flexion isometric strength 
were measured using a KinCom Dynamometer (KinCom 125AP, KinCom, USA) on the self-
reported dominant limb. Participants were seated, with the tested limb, chest and hips 
stabilised and with the knee and elbow angle positioned at 70 degrees of flexion, 
respectively. After familiarisation, participants performed 3 maximal voluntary contractions, 
the greatest of which was recorded.  
Dietary analysis: Between visits 1 and 2, participants were provided with a 4-day weighed 
food diary designed to capture habitual food intake on 2 consecutive weekdays and 2 
weekend days. Participants were instructed not to change their usual diet and to be as 
accurate as possible when describing the food (cooking method, brand, amount etc.). Dietary 
intake was analysed using MyFitnessPal software (MyFitnessPal Inc.).  
Physical Activity: Between visits 1 and 2 (~7 days), participants were provided with a wrist-
worn accelerometer (GENEActiv, ActivInsights Ltd., UK) designed to capture habitual 
activity in free-living conditions over 5 consecutive days (including both weekend days). 
Accelerometers were initialized to sample data at a 10 Hz. Data were converted into 60 
second epochs and analysed using the GENEActiv software (version 2.2, ActivInsights). 
Activities were split into 4 categories based on metabolic equivalent (MET) values; i) 
sedentary activity (<1.5 METs) ii) light activity (1.5 – 3.99 METs) iii) moderate activity (4.0 
– 6.99 METs) and iv) vigorous activity (>7 METs) 24. 
 
Visit 2  
Muscle architecture: B-mode ultrasonography with a linear array probe was used for all 
measurements of muscle architecture. Participants lay fully relaxed in a supine position with 
a small towel rolled and placed under the knee for anterior measurements. For posterior 
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measurements, participants were in a fully relaxed prone position with feet overhanging the 
end of the bed. Biceps Brachii architecture was measured with the participants seated on the 
edge of the bed with the arm freely hanging. The muscles measured included; Vastus 
Lateralis, Vastus Intermedius, Rectus Femoris, Biceps Brachii, Gastrocnemius Medialis, and 
Tibialis Anterior. Measurements of muscle thickness (MT), pennation angle (θ) and fascicle 
length (Lf) were made in triplicate.  MT was considered to be the distance between deep and 
superficial aponeuroses. θ was calculated as the angle between the muscle fascicle and the 
deep aponeurosis. Fascicle length was measured as the length of the fascicular path between 
the 2 aponeuroses. Measurement sites were set at 60% of the upper arm length distal to the 
acromion process for Biceps Brachii, 50% of the muscle length for upper thigh muscles, and 
30% of the leg length distal to the popliteal crease for lower leg muscles. The ultrasound 
probe was covered with water-soluble transmission gel, to provide acoustic contact without 
compressing the dermal surface, and an image was taken when a number of fascicles could 
clearly be identified. 
Blood sample: A blood sample was obtained via venepuncture from an antecubital forearm 
vein. Blood was collected in separate ethylenediaminetetraacetic acid (EDTA) and serum-
separating polymer gel containing BD vacutainers (BD, Oxford, UK). Blood samples were 
centrifuged at 3000g for 10 min at 4°C, and serum and plasma aliquots were frozen at −80°C 
for later analysis. 
Muscle Biopsy: A muscle biopsy sample was obtained from the quadriceps vastus lateralis 
under local anaesthesia (1% lidocaine) using the Bergström needle technique 25. Muscle 
biopsy tissue was quickly rinsed in ice-cold saline and blotted to remove any visible fat and 
connective tissue before being frozen in liquid nitrogen or placed in a pipette tip with 
optimum cutting temperature compound (Tissue-Tek® (O.C.T.) Compound, Sakura® 
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Blood samples: Plasma glucose was analysed using a commercially available blood glucose 
analyser (HemoCue® Hb 201+ System, HemoCue AB, Sweden). Serum insulin and C-
reactive protein (CRP) were analysed using commercially available enzyme-linked 
immunosorbent assay (ELISA) kits (IBL International GmbH, Hamburg, Germany) 
following the manufacturer instructions. Postabsorptive insulin sensitivity was also estimated 
using the homeostasis model of insulin resistance index (HOMA-IR) 26. 
Immunohistochemistry:  
Detailed information on primary and secondary antibodies for immunohistochemistry is 
presented in Supplemental Table 1. For analysis of myonuclear domain, SC content and 
myofibre capilliarisation muscle cross sections were stained as follows. Briefly, tissue 
sections were fixed in 4% paraformaldehyde (PFA) for 10 min, washed 3 x 5 min in PBST, 
blocked for 60 min at RT (in PBS containing 2% bovine serum albumin, 5% FBS, 0.2% 
Triton x-100, 0.1% NaAzide, and 2% goat serum) then incubated overnight in  
primary antibodies specific for Pax7 and CD31at 4°C. Following washes, sections were then 
incubated in appropriate secondary antibodies for 2 hours. Following washes sections were 
then re-blocked in 10% goat serum in PBS and incubated in a primary antibody cocktail 
consisting of MHC I (A.4.951; slow isoform) and laminin. Sections were washed then 
incubated in a secondary antibody cocktail, nuclei were labelled with DAPI (49,6-diamidino-
2-phenylindole) (1:20000, Sigma-Aldrich, Oakville, ON, Canada) prior to cover slipping 
with DAKO fluorescent mounting media (Burlington, ON, Can). Slides were visualised with 
the Nikon Eclipse Ti Microscope (Nikon Instruments, Inc., Melville, NY, USA), equipped 
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with a high-resolution Photometrics CoolSNAP HQ2 fluorescent camera (Nikon 
Instruments). Images were captures and analysed using the Nikon NIS Elements AR 3.2 
software (Nikon Instruments). All images were obtained on the x20 objective.  
i) Muscle Fibre Type and Cross-sectional area:  This analysis was carried out on a subset of 
participants (YC; n=13: MA; n=14: OC; n=11). Serial 10µm sections of skeletal muscle 
biopsies were cut in the cryostat at -20°C. Briefly, slides were washed in triton x100 (0.02 %) 
to permeabilise the fibres. Slides were blocked for 90 mins in 5 % normal goat serum 
(Invitrogen, UK) and then incubated overnight in the primary antibody cocktail; myosin 
heavy chain (MHC) I, BAF8 (Developmental Studies Hybridoma Bank (DSHB, USA); MHC 
II, SC-71 (DSHB, USA); Laminin in phosphate buffered saline (PBS).  Slides were washed 
in 3 x 5 min in PBST and incubated in the secondary antibody cocktail. Slides were then 
washed and mounted with coverslips in prolong gold anti-fade mountant (Thermo Fisher 
Scientific, Paisley, UK). Prepared slides were observed under a Nikon E600 microscope 
using a 20 × 0.75 numerical aperture objective. Images per area were captured under two 
colour filters achieved by a SPOT RT KE colour three-shot CCD camera (Diagnostic 
Instruments Inc., MI, USA), illuminated by a 170 W Xenon light source. Texas red (540–580 
nm) excitation filter was used to capture MHC I images and FITC (465– 495 nm) excitation 
filter was used to capture MHC II and Laminin. Microscope slides were prepared such that 
each slide contained two serial sections from one individual from each of the included 
groups. Images were captured, and measured, such that ~ 600-1000 muscle fibres were 
included for analysis from each group. All viable muscle fibres in any particular image, 
excluding those displaying freeze fracture artefact and any longitudinal fibres (assessed as 
those with a circularity of <0.6), were included for analysis and were analysed using Image J 
Fiji 27. 
Calculations and Measurements:  
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i) Myonuclear domain: This analysis was carried out on a subset of participants (YC; n=10: 
MA; n=12: OC; n=11). From acquired images specific channels were extracted so that only 
MHC I, laminin and DAPI were visualised. Myonuclear domain was determined as the fibre 
area of MCH I and MHC II fibres (µm2) per nucleus. Only nuclei that were located within the 
basal lamina as identified by laminin were counted. Myonuclear content was determined by 
counting the number of nuclei residing within the basal lamina of either Type I (MHC I 
positive) or Type II (MHC I negative) fibres expressed in relation to total MHC I and MHC 
II fibres. 
ii) Myofibre capillary analysis: This analysis was carried out on a subset of participants (YC; 
n=10: MA; n=11: OC; n=11). From acquired images specific channels were extracted so that 
only MHCI, laminin and CD31 were visualised. Quantification of (i) capillary contacts (CC, 
the number of capillaries around a fibre), (ii) the capillary‐to‐fibre ratio on an individual fibre 
basis (C/Fi), (iii) the number of fibres sharing each capillary (i.e., the sharing factor), and (iv) 
the capillary-to-fibre perimeter exchange index (CFPE index, calculated as the C:Fi/P, where 
P is the fibre perimeter) was based on previous published protocols 28,29.  
iii) Myofibre satellite cell analysis: This analysis was carried out on a subset of participants 
(YC; n=10: MA; n=11: OC; n=10). From acquired images specific channels were extracted 
so that only MHCI, laminin, Pax7 and DAPI were visualised. Fibre type specific SC content 
was determined by identifying nuclei co-localised with Pax7 that resided within the basal 
lamina.  
 
Statistical Analysis: Data were expressed as mean ± standard deviation (SD). Normality of 
data was assessed using the Shapiro-Wilk test. Between group differences in anthropometric 
characteristics, physical performance, dietary intake and habitual activity levels were 
identified via one-way ANOVA analysis with one within-group factor (e.g. fat-free mass) 
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and three groups for comparison. Muscle morphological data were analysed via mixed-design 
ANOVA with one between factor (three levels; group) and one within factor (two levels; 
fibre type). Specifically, the average of each participant’s data was incorporated into the 
grouped analyses. For example, when analysing fibre-specific CSA ~100 fibres were 
measured for each individual, following which, the average fibre-CSA for each individual 
was incorporated into the grouped analysis. Significant main effects indicated group 
differences with fibre-types collapsed (i.e., MA vs. OC vs. YC for MHC I and II combined), 
or fibre-type differences with groups collapsed (i.e., MHC I vs. MHC II for MA, OC, and YC 
combined). Significant interaction effects indicated that age and/or training status (group; 
YC, MA, OC) influenced a given fibre-type parameter (i.e. MHC I CSA). Whenever a 
significant F ratio was found (i.e. variation between sample means), interaction or main 
effects were followed up with pair-wise comparisons using independent t-tests to locate 
specific differences, with the Bonferroni correction applied to account for multiple 
comparisons. Significance level was set at P < 0.05 for all analyses. All statistical analyses 
were performed using SPSS version 22.0 (Chicago, IL). 
 
RESULTS 
Participant Characteristics: Participant anthropometric and training characteristics are 
detailed in Table 1. YC were taller than MA (P=0.031). MA had lower whole-body fat mass 
(P=0.011), a lower body fat percentage (P=0.002) and a greater skeletal muscle index 
(P=0.001) than OC. YC had significantly greater appendicular lean mass than OC (P=0.03). 
YC and MA had significantly lower fasting glucose concentrations than OC (P=0.005 and 
P=0.009, respectively). MA had significantly lower serum insulin (P=0.048 and P=0.041) 
and HOMA-IR (P=0.03 and P=0.003) than YC and OC, respectively. There were no other 
significant differences in anthropometric characteristics between the groups.  
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Physical Function: Physical function characteristics are detailed in Table 2. There were no 
significant differences between groups for any of the SPPB component nor total scores or 
handgrip strength. YC produced significantly greater knee extension MVC than MA and OC 
(P=0.006 and P<0.001, respectively), although no difference was apparent when normalized 
to leg fat-free mass (FFM) indicating no between-group difference in relative force 
production. YC produced significantly greater elbow flexion than MA (P<0.001) that was 
apparent when normalized to arm FFM (P<0.05), indicating lower relative force production 
in MA vs. YC.  YC and MA had a significantly greater estimated V̇O2max than OC (P<0.001).  
Muscle architecture: Muscle architecture results are detailed in Supplementary Table 2. YC 
had significantly greater MT than OC for Vastus lateralis (P<0.001), Vastus intermedius 
(P=0.002), Rectus femoris (P<0.001) and greater MT than MA for Rectus femoris (P<0.001). 
YC had significantly greater θ than OC for Vastus lateralis (P=0.007), Vastus intermedius 
(P=0.014), Rectus femoris (P=0.002) and significantly greater θ than MA for Rectus femoris 
(P=0.04). MA had significantly greater Lf than OC for Gastrocnemius medialis (P=0.032) 
and YC had significantly greater Lf than OC (P=0.024) and MA (P=0.041) for 
Gastrocnemius lateralis.  
Habitual Dietary Intake and Physical Activity: Dietary intake results are detailed in 
Supplementary Table 3 (upper). YC total energy (P=0.014), fat (P=0.019), protein (P<0.001), 
relative fat (P=0.044) and relative protein intake (P=0.005) were greater than OC. Whereas, 
MA total energy (P=0.003), carbohydrate (P=0.014), relative carbohydrate (P=0.008), 
relative fat (P<0.007) and relative protein intake (P=0.029) were greater than OC. No 
differences in dietary intake were observed between YC and MA. Habitual activity can be 
found in Supplementary Table 3 (lower). MA carried out significantly more vigorous activity 
(49 ± 29 mins·day-1 or 5.6 ± 3.2%·day-1) than both YC (13 ± 14 mins·day-1, 1.7 ± 1.5%·day-1; 
 15 
P<0.001) and OC (4 ± 6 mins·day-1, 1.1 ± 2.6% day-1; P<0.001). There were no other 
differences in physical activity between groups.  
Muscle fibre properties: Muscle fibre data are detailed in Figure 1 A-E. A significant 
interaction effect of group*fibre type CSA was observed (P<0.001). MA displayed larger 
MHC I fibre CSA than OC (P=0.031), whereas YC had significantly larger MHC II fibre 
CSA than OC (P=0.008). A significant interaction effect of group*fibre type distribution was 
observed (P<0.001). MA (57 ± 15 %) had a significantly greater proportion of MHC I muscle 
fibres compared with YC (35 ± 10 %, P<0.001) and OC (41 ±10 %, P=0.008). MA (43 ± 15 
%) had a significantly lower proportion of MHC II fibres compared with YC (65 ± 10 %, 
P<0.001) and OC (58 ± 10%, P=0.012).  
Myonuclear domain: Muscle fibre data are detailed in Figure 2 A-E. A significant 
interaction effect of group*fibre type myonuclear domain was observed (P=0.04). No 
significant difference was observed between any of the groups for MHC I fibre myonuclear 
domain. YC had significantly greater MHC II fibre specific myonuclear domain than MA 
(P=0.018) and OC (P=0.006). No significant interaction effect for group*fibre type 
myonuclei content was observed. 
Capillarisation and satellite cells: Capillarisation and SC data are detailed in Figure 1 A-G 
and Supplementary Figure 1 A-C, respectively. A significant interaction effect of group*fibre 
type capillary contacts (CC) was observed (P=0.007). MA had significantly more CC per 
MHC I myofibre compared with YC and OC (P=0.002 and P<0.001, respectively). MA had 
more CC per MHC II fibre compared with OC (P=0.006). A significant interaction effect of 
group*fibre type capillary-fibre ratio (C/Fi) was observed (P=0.007). MHC I C/Fi was 
greater in MA compared with YC and OC (P=0.001 and P=0.001, respectively). MA had a 
greater MHC II C/Fi than OC (P=0.004). No significant interaction effect of group*fibre type 
capillary to fibre perimeter exchange index (CFPE) was observed. However, CFPE showed a 
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significant main effect for group, such that MA had a significantly greater CFPE compared 
with YC (P=0.001) an OC (P=0.001). No significant interaction (group*fibre type) or main 
effects (group and fibre type alone) were observed for SC content. 
 
DISCUSSION 
Ageing has a deleterious effect on physiological function, muscle mass, and strength 
(sarcopenia) and muscle oxidative capacity that may be exacerbated by low physical activity 
or adverse change in body composition. Individuals who have chronically undertaken 
structured exercise training, or Master Athletes (MA), provide an opportunity to study 
mechanisms of inherent physiological ageing dissociated from aspects of biological ageing 15. 
Previously, we have highlighted the dearth of studies providing a comprehensive 
characterisation of the MA phenotype against untrained young and older individuals 14. 
Herein, we comprehensively address this issue by firstly demonstrating that endurance-
trained MA display superior body composition (lower body fat and higher skeletal muscle 
mass index) and aerobic fitness compared with untrained age-matched older individuals 
(OC), to a level comparable with untrained healthy young individuals (YC). Secondly, we 
provide novel morphological insights demonstrating that MA display larger MHC I muscle 
fibre area than OC. Furthermore, MA display greater capilliarisation of MHC I and II fibres 
compared with OC and YC. MHC II fibre myonuclear domain size was greater in YC 
compared with OC and MA, whereas SC content was similar between groups. Collectively, 
these data suggest that chronic endurance training promotes superior aerobic capacity, body 
composition and fibre capilliarisation, with potential implications for healthspan extension.  
Sarcopenia is often accompanied, and in some cases masked, by increased adiposity 30 
and ectopic and visceral fat deposition 11,31. Reduced muscle mass and increased body fat are 
independently and concomitantly associated with increased risk of metabolic disease 32, 
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frailty 33, and mortality 34. Thus, the absence of sufficient physical activity in the face of 
surplus energy intake in older age, increases the likelihood of unfavourable changes in body 
composition (i.e., reduced muscle mass and increased body fat). Furthermore, periods of 
inactivity and disuse impair muscle protein anabolism and accelerate the progression of 
sarcopenia 35. Our data demonstrate that highly active MA had a greater skeletal muscle 
index, lower body fat and lower whole-body insulin resistance than OC. Thus, continuation 
of structured endurance exercise training promotes a favourable body composition and could 
confer important metabolic health benefits. 
Age-related muscle mass and strength loss involves alterations in architectural 
properties and fibre-type morphology. With ageing, muscle fibre fascicle length and 
pennation angle decrease, indicating a loss of sarcomeres (in series and parallel)36. To the 
best of our knowledge, we are the first to measure muscle architecture in an endurance 
trained MA cohort, for comparison against YC and OC. Our novel findings demonstrate that 
muscle fibre fascicle length and pennation angle properties were generally lower in OC and 
MA, compared with YC, with no differences between MA and OC. Similarly, others have 
reported equivalent vastus lateralis fascicle length between young and old sprint athletes 37. 
Important to note however, was that fibre pennation angle and fascicle length of the vastus 
intermedius and gastrocnemius medialis, respectively, were statistically greater in YC 
compared with OC only, with no difference between OC and MA. These data indicate that 
the alterations to muscle architectural properties with advancing age are not preserved with 
chronic endurance exercise training. The observed architectural modifications in MA and OC 
may attenuate the decreased force production with age-related muscle loss. Indeed, isometric 
knee extensor strength was similar between groups when normalized to leg fat-free mass. 
Although normalized isometric biceps strength was lower in MA compared with YC, 
technical limitations prevented us from understanding whether alterations to the architectural 
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properties of this muscle could explain this deficit. Nonetheless, it is apparent that contractile 
loading in the form of resistance training may be required to generate sufficient mechanical 
tension to enhance muscle architectural properties and mitigate strength declines in older 
individuals 14,38. 
 Reductions in muscle fibre number and area, particularly MHC II fibres, is a 
characteristic of sarcopenia 8. In older individuals, resistance training increases MHC II fibre 
area, whereas endurance exercise training primarily augments MHC I fibre area 14. Skeletal 
muscle morphology data in MA are scarce, and available studies have yielded conflicting 
findings 14,17,18, making it difficult to fully elucidate the mechanisms through which chronic 
exercise enhances physiological function. In line with previous findings 18,39, we demonstrate 
that endurance trained MA have larger MHC I fibres than OC, and a greater proportion of 
MHC I fibres compared with YC and OC. Compared with OC, the superior MHC I fibre 
properties of MA suggests that their greater maximal aerobic capacity may be partly 
underpinned by a greater muscle oxidative potential, although cardiorespiratory adaptations 
undoubtedly also play a key role in VO2max. Unsurprisingly, MHC II fibre size was lower in 
OC compared with YC. However, chronic endurance exercise did not preserve MHC II fibre 
size, which was similar between MA and OC. Due to technical limitations, we were only able 
to analyse two fibre types. Given evidence that ageing leads to a reduction in MHC IIA 
fibres, an increased proportion of fibres co-expressing different MHC isoforms and that 
physical activity can offset these alterations 40, future investigations should seek to determine 
more specific and hybrid fibre-types. Nevertheless, the current data suggest that chronic 
endurance exercise elicits a mode-specific remodelling of muscle fibres, such that MHC I 
fibre area and/or abundance is greater than OC and YC.  
Skeletal muscle SC, as the main source of new myonuclei, play an important role in 
the repair and regeneration of skeletal muscle 41. Given that age-related MHC II fibre atrophy 
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is accompanied by a reduction in MHC II SC, and that SC content is a strong predictor of 
muscle fibre size in older individuals 42,43, reductions in SC may impair the capacity for 
muscle maintenance in old age. As such, we were surprised to find no age-related difference 
in fibre-specific SC content between YC and OC. However, the absence of any effect of 
chronic endurance exercise on SC content (per fibre) is consistent with the work of Mackey 
and colleagues 17 and aligned to evidence that the SC pool remains constant in response to 
endurance-based training programmes in humans 44. The absence of any difference in fibre-
specific SC within or between groups, could be due to a large within-group variability in the 
sub-set of samples available for analysis. In addition to SC content, SC activity is critical for 
muscle repair and regeneration with exercise-induced damage. SC activity is reportedly 
delayed in older individuals 45, increases with endurance training 44 and could therefore be 
maintained in MA and warrants further investigation. The area of the cell governed by each 
myonucleus (myonuclear domain) has been reported to diminish in older age 42. Our findings 
provide support for an age-related reduction in myonuclear domain in MHC II, but not MHC 
I, fibres. Interestingly, the age-related reduction in fibre-type myonuclear domain size was 
not offset in MA, analogous to findings from the only other investigation of myonuclei in 
chronically endurance trained MA 17. Taken together, these data indicate that larger MHC I 
fibre area in MA vs. OC, occurs independently of alterations in SC content or myonuclear 
domain, which appear relatively constant with ageing and chronic endurance training. Further 
to this, the age-related diminution of MHC II fibre myonuclear domain in MA and OC 
appears to precede any change in SC content.  
Impairments in muscle perfusion and the delivery of oxygen and nutrients to skeletal 
muscle from nearby capillaries, may impair muscle oxidative capacity and contribute to the 
development of impaired muscle anabolism and sarcopenia. Indeed, capillary density is 
reduced in older age, particularly in MHC II fibres 46, thereby impairing muscle fibre 
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perfusion. In older muscle, the capillary-to-fibre ratio and the capillary-to-fibre perimeter 
exchange index is reduced, and the distance between satellite cells and the nearest capillary is 
greater in MHC II fibres compared with younger individuals 9. This may have consequences 
for the responsiveness of SC to facilitate skeletal muscle repair and remodelling processes in 
response to contraction-induced muscle damage. In contrast to the findings of Nederveen et 
al. 9, we did not observe any age-related reduction of indices of capilliarisation, which may 
be reflective of the greater aerobic capacity of our OC cohort (~10.0 mL·kg-1·min-1 greater 
than Nederveen et al). Nevertheless, it is clear from our results that chronic endurance 
exercise training leads to greater MHC I and II fibre capilliarisation in MA compared with 
OC and, in some cases, YC. These findings are consistent with recent evidence that the 
continuation of endurance training into older age maintains skeletal muscle capilliarisation 47. 
However, recent evidence from a cross-sectional analysis of highly trained MA (55-79 y) 
suggests that chronic endurance training does not completely prevent the decline in capillary 
density 12. Nevertheless, the greater muscle fibre capilliarisation and MHC I fibre area 
observed in our cohort of endurance-trained MA may, at least partly, explain their superior 
aerobic fitness levels. 
Whilst our findings clearly demonstrate superior indices of physiological function and 
muscle morphology in MA compared with OC, we are unable to determine whether chronic 
endurance exercise offsets the trajectory of age-related physiological deterioration. The 
cross-sectional nature of this study, and absence of a young endurance trained cohort 
precludes us from determining how chronic exercise influences the rate of physiological 
decline. However, evidence suggests that MA experience a similar, or greater rate of 
physiological and functional deterioration compared with their untrained age-matched 
counterparts 15,16, but the ‘set-point’ from which this deterioration begins is delayed (or 
postponed) in MA 15. Although chronic exercise training may lower the risk of disease and 
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disability in later life 48, the apparent shift to a ‘slow’ muscle phenotype (and reduction in 
MHC II fibre proportion) that we and others have observed in endurance-trained MA could, 
paradoxically, be viewed as a hallmark of aggravated sarcopenia 49. However, others have 
recently reported that long-term athletic training (strength or endurance) facilitates more 
successful reinnervation of denervated muscle fibres 50, which would strongly influence final 
MHC expression. Thus, it would be prudent to examine whether the observed differences in 
physiological function, strength and muscle morphology between endurance-trained MA and 
OC, are further modified in very old age (i.e. >80 y). Ultimately, the inclusion of resistance-
type exercise, may help to preserve strength and physical function in endurance-trained MA 
39. To date, studies of physiological function and muscle morphology in strength/power 
trained MA are scarce.  
In conclusion, our findings demonstrate that endurance-trained MA with an average 
of ~37 years of training experience display superior aerobic capacity, body composition and 
indices of muscle fibre morphology compared with age-matched untrained older individuals. 
Irrespective of whether chronic endurance exercise offsets the rate of age-related 
physiological deterioration, or simply delays the point from which this decline begins, the 
novel insights shown here shed light on the extent to which chronic endurance training 
supports physical function and skeletal muscle health in older age, with implications for 
healthspan extension. Thus, the promotion of regular physical activity across the life-course, 
that incorporates endurance and strength training, may offer the greatest level of protection 
against the decline in physiological health and function with advancing age.  
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TABLES 








Age (years) 20.0 ± 2.7**## 67.1 ± 6.4 69.8 ± 4.1 
Height (m) 1.80 ± 0.04* 1.70 ± 0.06 1.80 ± 0.07 
Body mass (kg) 78.9 ± 13.3 68.7 ± 6.6 77.5 ± 14.2 
BMI (kgm-2) 24.6 ± 3.6 23.0 ± 2.0 24.5 ± 3.8 
Whole-body FFM (kg) 56.9 ± 6.6 52.2 ± 3.5 52.9 ± 7.8 
Whole-body FM (kg) 17.6 ± 7.4 13.3 ± 3.9# 20.9 ± 7.1 
Body fat (%) 22.0 ± 5.5 19.2 ± 4.1## 26.8 ± 5.4 
Skeletal Muscle Index (%) 74.0 ± 5.2 77.0 ± 4.0## 69.8 ± 5.1 
ALM/Height2 (kg.m-2) 8.18 ± 0.79# 7.71 ± 0.54 7.39 ± 0.95 
Systolic Blood Pressure (mmHg) 126 ± 9 125 ± 7 137 ± 18 
Diastolic Blood Pressure (mmHg) 64 ± 8 76 ± 7 83 ± 11 
Fasting Plasma Glucose (mmol·L-1)   5.33 ± 0.39## 5.35 ± 0.63## 5.96 ± 0.35 
Fasting Serum Insulin (µIU/mL) 10.95 ± 3.24* 7.21 ± 3.10 11.42 ± 4.38* 
HOMA-IR  2.59 ± 0.75** 1.65 ± 0.61 3.05 ± 1.16** 
CRP (mg·L-1) 1.71 ± 1.89 0.77 ± 0.43 1.10 ± 0.53 
Training Experience (years) - 36.5 ± 8.1 - 
Training Frequency (sessions·week-1) - 4.5 ± 1.4 - 
Training Duration (hrs·week-1) - 7.6 ± 4.7 - 
Training Distance (km·week-1) - 210±12 / 50 ±15 - 
 
Data presented as mean ± SD. FFM; fat-free mass, FM; fat mass, ALM; appendicular lean mass, 
HOMA-IR; Homeostatic Model Assessment of Insulin Resistance, CRP; C-reactive protein. Training 
Distance is separated into cyclists (n=8, left) and runners (n=6, right). * Indicates significantly 
different from MA, P<0.05. ** Indicates significantly different from MA, P<0.01. # Significantly 




Table 2: Physical function and strength 
 
Data presented as mean ± SD. * Indicates significantly different from MA, P<0.05. ** 
Indicates significantly different from MA, P<0.01. # Indicates significantly different from 
OC, P<0.05. ## Indicates significantly different from OC, P<0.01. SPPB; short physical 
performance battery. MVC; maximal voluntary contraction. Nm; Newton metres. FFM; fat-














SPPB Standing Balance (s) 10.0 ± 0 10.0 ± 0 10.0 ± 0 
SPPB Semi-Tandem (s) 10.0 ± 0 10.0 ± 0 10.0 ± 0 
SPPB Full Tandem (s) 10.0 ± 0 9.7 ± 1.0 9.7 ± 1.1 
SPPB 3m Walk (s) 2.37 ± 0.34 2.43 ± 0.28 2.45 ± 0.44 
SPPB 5x Sit-to-stand (s) 7.27 ± 1.34 7.97 ± 1.88 7.88 ± 2.03 
Handgrip Strength (kg) 50.9 ± 7.6 47.0 ± 5.9 46.3 ± 8.4 
Knee Extension MVC (Nm)  638 ± 82**## 520 ± 105 471 ± 118 
Knee Extension MVC (Nm·kg-1 leg FFM) 68 ± 9 62 ± 13 57 ± 13 
Elbow Flexion MVC (Nm) 293 ± 49** 223 ± 43 257 ± 49 
Elbow Flexion MVC (Nm·kg-1 arm FFM) 79 ± 9* 68 ± 12 77 ± 10 
Estimated V̇O2max (ml·kg-1·min-1) 53.2 ± 7.3## 49.3 ± 3.6## 36.7 ± 6.5 
Estimated V̇O2max (ml·kg-1 FFM-1·min-1) 72.7 ± 5.8##** 65.2 ± 3.4## 53.3 ± 8.7 
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Figure 1: Cross-sectional area (CSA) of MHC I (A) and MHC II muscle fibres (B) and 
relative abundance of MHC I (C) and MHC II muscle fibres (D) in young untrained 
individuals (YC), old endurance trained Master Athletes (MA) old untrained individuals 
(OC). Representative immunohistochemical image of muscle fibre CSA from a biopsy 
sample in YC (left), MA (centre) and OC (right) with MHC I fibre MHC in red, MHC II fibre 
MHC in green and laminin stained cell membrane in green (E). Significance was set at P < 
0.05. # indicates significantly different from OC (P < 0.05) and * indicates significantly 
different from MA (P < 0.05). Values are presented as the median (central horizontal line), 
25th and 75th percentiles (box), minimum and maximum values (vertical lines) and mean 
(cross). 
 
Figure 2: Myonuclear domain in MHC I (A) and MHC II muscle fibres (B) and number of 
nuclei per MHC I (C) and MHC II muscle fibre (D) in young untrained individuals (YC), old 
endurance trained Master Athletes (MA) old untrained individuals (OC). Representative 
immunohistochemical image of fibre-type myonuclei from a biopsy sample in YC (left), MA 
(centre) and OC (right) with DAPI stained nuclei in blue, MHC I fibre MHC in green and 
laminin stained cell membrane in green (E). Significance was set at P < 0.05. # indicates 
significantly different from OC (# P < 0.05 and ## P < 0.01), * indicates significantly 
different from MA (P < 0.05). Values are presented as the median (central horizontal line), 
25th and 75th percentiles (box), minimum and maximum values (vertical lines) and mean 
(cross). 
 
Figure 3: Capillary contacts per fibre (CC), individual capillary to fibre ratio (Cfi) and 
capillary to fibre perimeter exchange index (CFPE) in MHC I fibres (A, C and E, 
respectively) and MHC II fibres (B, D and F, respectively), in young untrained individuals 
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(YC), old endurance trained Master Athletes (MA) old untrained individuals (OC). 
Representative immunohistochemical image of fibre-type capilliarization from a biopsy 
sample in YC (top), MA (middle) and OC (bottom) with CD31 stained capillaries in purple 
(denoted by white arrows), MHC I fibre stained in green and laminin stained cell membrane 
in green (G). Significance was set at P < 0.05. ## indicates significantly different from OC (P 
< 0.01), †† indicates significantly different from YC (P < 0.01). Values are presented as the 
median (central horizontal line), 25th and 75th percentiles (box), minimum and maximum 
values (vertical lines) and mean (cross). 
